Skip to main
MNKTQ

Mallinckrodt PLC (MNKTQ)


$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Mallinckrodt PLC (MNKTQ) Stock

About Mallinckrodt PLC (MNKTQ)

Keenova Therapeutics PLC provides pharmaceutical products. The private company is based in Dublin, Ireland. and has a global presence of subsidiaries in several regions. The Irish company was founded in 1867 by Edward Mallinckrodt, Gustavo Mallinckrodt, Otto Mallinckrodt. Sigurdur Oli Olafsson has been the CEO of the company since 2022. Keenova Therapeutics was acquired by Shareholders from Covidi...read more
Market cap
Today's volume
Revenue (TTM)
Avg. daily volume
EBITDA (TTM)
Open
Price / earnings ratio
Today's range
Debt / equity
52 week range
5 year debt / equity
Beta (LTM)
Interest coverage
Dividend & yield— (—)
Current ratio
Ex-dividend date
Next earnings
Dividend payable date

Frequently Asked Questions (FAQ)

How to buy MNKTQ stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in MNKTQ stock

    Navigate to the Explore page. Then, type MNKTQ into the search bar. When you see MNKTQ stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased MNKTQ stock in your portfolio alongside the rest of your stocks, ETFs, crypto, bonds, options, and your high-yield cash account––all in one place on Public.

Buy Mallinckrodt PLC (MNKTQ) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.